HUTCHMED (China) Ltd
00013
Company Profile
Business description
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Contact
2 Queen's Road Central
48th Floor, Cheung Kong Center
Hong Kong
HKGT: +852 21218200
E: ir@chi-med.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2024
Employees
1,990
Stocks News & Analysis
stocks
One of the hottest shares on the ASX reports strong growth
Should investors chase this growth story or are they overvalued after the surge in the shares.
stocks
Diverging value in Australia's real estate sector
One stock dominates Australia's A-REIT index and it has had an incredibly strong year. Our analysts see value elsewhere.
stocks
Going into earnings, is Amazon stock a buy, a sell, or fairly valued?
We will be watching what Amazon has to say on AWS, advertising, and generative AI in its upcoming earnings release. Here’s what we think of Amazon’s stock.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,094.30 | 111.20 | -1.36% |
| CAC 40 | 7,397.69 | 116.04 | -1.54% |
| DAX 40 | 18,181.48 | 205.98 | -1.12% |
| Dow JONES (US) | 39,853.87 | 504.22 | -1.25% |
| FTSE 100 | 8,084.63 | 69.06 | -0.85% |
| HKSE | 17,004.97 | 306.08 | -1.77% |
| NASDAQ | 17,342.41 | 654.94 | -3.64% |
| Nikkei 225 | 37,869.51 | 1,285.34 | -3.28% |
| NZX 50 Index | 12,396.27 | 134.72 | -1.08% |
| S&P 500 | 5,427.13 | 128.61 | -2.31% |
| S&P/ASX 200 | 7,861.20 | 102.50 | -1.29% |
| SSE Composite Index | 2,886.74 | 15.21 | -0.52% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Sayona Mining Ltd SYA | 0.03 | 0.00 | -3.13% |
| Argosy Minerals Ltd AGY | 0.03 | 0.02 | -30.61% |
| Pilbara Minerals Ltd PLS | 2.87 | 0.02 | -0.69% |
| Telstra Group Ltd TLS | 3.84 | 0.06 | -1.54% |
| Red 5 Ltd RED | 0.40 | 0.02 | -4.82% |
| South32 Ltd S32 | 2.91 | 0.05 | -1.69% |
| Zip Co Ltd ZIP | 1.81 | 0.02 | -0.82% |
| Peninsula Energy Ltd PEN | 0.10 | 0.01 | -4.76% |
| Core Lithium Ltd CXO | 0.09 | 0.00 | -3.19% |
| Medibank Private Ltd MPL | 3.83 | 0.00 | 0.00% |